Delivery Order SPE2DR25D1017-SPE2DR26F9BBB
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $11,891.14 to AmerisourceBergen Drug Corp for Dexcom G7 sensors. The contract, which became effective on June 18, 2025, with an ultimate completion date of June 20, 2025, represents a firm fixed price procurement with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfilled this order under its existing Indefinite Delivery Contract with DLA...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $10,436.08 to AmerisourceBergen Drug Corp for the supply of Dexcom G7 sensors. This competitive, firm fixed-price contract was executed on December 3, 2025, with an ultimate completion date of December 4, 2025. The delivery order will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child contract under a larger vehicle, this delivery order leverages AmerisourceBergen's existing...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,976.66 to AmerisourceBergen Drug Corp for Dexcom G7 sensors on December 9, 2025, with a completion date of December 10, 2025. This firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The award was competitively made without a set-aside designation, and performance...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,364.54 to AmerisourceBergen Drug Corp for Dexcom G7 sensors on October 24, 2025, with an ultimate completion date of October 27, 2025. This firm fixed-price delivery order is not set-aside and represents a competitive award to the pharmaceutical distributor's Corporate Office division, headquartered in Conshohocken, Pennsylvania. The award falls under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency awarded a delivery order valued at $1,621.69 to AmerisourceBergen Drug Corp for Dexcom G7 sensors, with a completion deadline of October 27, 2025. This is a firm fixed-price, non-set-aside contract performed at the contractor's location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, has been selected to deliver this medical device as part of its ongoing support to federal health...
- The Defense Logistics Agency awarded a delivery order valued at $4,871.27 to AmerisourceBergen Drug Corp for Dexcom G7 continuous glucose monitoring sensors. This firm fixed-price, competitively awarded contract was finalized on August 14, 2025, with an ultimate completion date of August 15, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a $3,278.84 delivery order contract to AmerisourceBergen Drug Corp for Dexcom G7 continuous glucose monitoring sensors. The contract, which is non-set-aside and competitively awarded, carries a firm fixed price structure with an ultimate completion date of September 18, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $3,361.44 to AmerisourceBergen Drug Corp for Dexcom G7 continuous glucose monitoring sensors. The contract is firm fixed price with no set-aside designation and carries an ultimate completion date of August 6, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency has awarded a delivery order valued at $1,694.39 to AmerisourceBergen Drug Corp for Dexcom G7 sensors. This firm fixed price, competitively awarded contract was issued on September 22, 2025, with an ultimate completion date of September 23, 2025. The delivery will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Dexcom G7 sensors, with a ceiling value of $1,787.20. This competitively awarded, firm fixed-price delivery order is scheduled for completion by August 29, 2025, and will be performed at the contractor's corporate office in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- SPE2DR25D1017Indefinite Delivery Contract
- SPE2DR25D1017-SPE2DR26F9BBBDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,039.91 to AmerisourceBergen Drug Corp for Dexcom G7 sensors under a non-competitive, firm fixed-price contract. The order was issued on December 9, 2025, with an ultimate completion date of December 10, 2025. AmerisourceBergen's Corporate Office division, headquartered in Conshohocken, Pennsylvania, will perform the work at that same location. This delivery order represents a child contract under AmerisourceBergen's larger $1 billion Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and running through December 2026. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal vendor supplying military and veteran healthcare systems through the DLA Medical Supply Chain. The company's federal contracting portfolio demonstrates extensive experience delivering a comprehensive range of medical products and pharmaceuticals, including specialty medications, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains. This particular order for continuous glucose monitoring sensors supports the Defense Health Agency's medical supply requirements and reflects AmerisourceBergen's established capability to fulfill federal healthcare procurement needs through open competition. The company is positioned as a key supplier in the DLA's Pharmaceutical Prime Vendor Global Program, which plans multiple regional awards to support worldwide military healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.0k | 12/8/25 |